Taiyen Biotech Co., Ltd. (TPE:1737)
29.25
-0.35 (-1.18%)
Nov 20, 2026, 1:30 PM CST
Taiyen Biotech Revenue
Taiyen Biotech had revenue of 825.05M TWD in the quarter ending September 30, 2026, with 1.26% growth. This brings the company's total for the last twelve months to 3.20B, down -2.24% year-over-year. In the year 2025, Taiyen Biotech had annual revenue of 3.31B with 2.15% growth. That makes Taiyen Biotech the 22,930th largest company in the world by revenue and 967th in Taiwan.
Revenue (ttm)
3.20B
Revenue Growth
-2.24%
P/S Ratio
1.83
Revenue / Employee
7.11M
Employees
450
Market Cap
5.85B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Taiyen Biotech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.31B | 69.51M | 2.15% |
| Dec 31, 2024 | 3.24B | -170.66M | -5.01% |
| Dec 31, 2023 | 3.41B | -204.80M | -5.67% |
| Dec 31, 2022 | 3.61B | -482.04M | -11.77% |
| Dec 31, 2021 | 4.10B | 965.30M | 30.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Yuen Foong Yu Consumer Products | 10.56B |
| TCI Co., Ltd. | 6.80B |
| Nan Liu Enterprise | 6.70B |
| Chlitina Holding | 4.09B |
| Shiny Brands Group | 3.64B |
| Sanitar | 2.70B |
| KNH Enterprise | 2.69B |
| Farcent Enterprise Co.,Ltd | 2.48B |